← Back
$EBS All transactions

Emergent BioSolutions Inc.

▼ SELL 10b5-1 Plan

$ Value

$49K

Shares

7,844

Price

$6

Filed

May 28

Insider

Name

Katkin Keith

Title

CIK

0001314596

Roles

Director

Transaction Details

Transaction Date

2025-05-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

86,431

Footnotes

Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated November 8, 2024, for the purpose of satisfying tax obligations relating to the vesting of RSUs on May 22, 2025. | For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $6.22 - $6.35. The Company maintains a record of the transactions and copies will be provided upon request.

Filing Info

Accession No.

0001367644-25-000136

Form Type

4

Issuer CIK

0001367644

Katkin Keith's History

Date Ticker Type Value
2026-02-04 SNDX A $0
2026-01-10 ELDN M $0
2026-01-10 ELDN M $0
2025-05-23 EBS $49K
2025-05-19 SNDX $91K
2025-04-30 EBS A $0
2025-04-30 EBS A $0

Other Insiders at EBS (90d)

Insider Bought Sold Last
FOWLER JOHN D JR 2026-03-03
LINDAHL RICHARD S
EVP, Chief Financial Officer
2026-03-05
PAPA JOSEPH C
President and CEO
2026-03-05
Glessner Coleen
EVP, Quality & Ethics, and CPL
2026-03-05
Williams Paul Anthony
SVP, Products Business
$34K 2026-04-01
Hartzel William
SVP, Bioservices
2026-03-05
Perl Jessica
SVP, General Counsel, Corp Sec
2026-03-05
Lowry Simon C
SVP, R&D, CMO
2026-03-05